Deciphera Pharmaceuticals, Inc.

Unity Biotechnology, a biotech firm developing drugs that eliminate or modulate senescent cells to treat diseases of aging, has been making the case for its approach in retinal diseases for the last f

China’s retaliatory tariffs mean the option of manufacturing US-originated drugs in China is making more sense than ever, at least to some local partners of US pharmaceutical companies. China imposed

The European Medicines Agency has begun reviewing a new batch of products for potential pan-EU marketing approval, including vimseltinib and a recombinant pertussis vaccine (RPV), both of which could

After a strong start to biopharma merger-and-acquisition activity in the first quarter of 2024, transactions declined notably in the second quarter, according to data provided by Evaluate. The second